Literature DB >> 9068484

Median arcuate ligament syndrome: a possible cause of idiopathic gastroparesis.

D H Balaban1, J Chen, Z Lin, C G Tribble, R W McCallum.   

Abstract

The median arcuate ligament syndrome (MALS) is characterized by abdominal pain, nausea, and vomiting attributed to compression of the celiac axis by a fibrous band (the median arcuate ligament) connecting the diaphragmatic crura. The pathophysiologic origin of these symptoms is not clearly understood. Theories invoking either a neurogenic or vascular origin for the clinical features associated with MALS have been proposed, but objective evidence to support these theories is lacking. We describe the clinical course and gastric myoelectrical features of a patient with postprandial epigastric pain, weight loss, gastroparesis, and gastric dysrhythmias in whom a diagnosis of MALS was established. Surgical decompression of the celiac axis in our patient resulted in resolution of abdominal pain, return to a full diet within 4 weeks without nausea or vomiting, improvement in radionuclide gastric emptying, and restoration of the gastric electrical rhythm to a normal 3 cycle/min conduction rate. This is the first demonstration of altered gastric myoelectrical activity in a patient with MALS. The regularization of the gastric electrical rhythm in our patient after surgical decompression of the celiac axis would support a neurogenic basis for the symptoms associated with MALS. MALS should be excluded in patients with idiopathic gastroparesis and unexplained epigastric pain.

Entities:  

Mesh:

Year:  1997        PMID: 9068484

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

Review 1.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

2.  Seconds from disaster: lessons learned from laparoscopic release of the median arcuate ligament.

Authors:  Kevin P Riess; Luke Serck; Sigurd B Gundersen; Michael Sergi; Shanu N Kothari
Journal:  Surg Endosc       Date:  2009-03-06       Impact factor: 4.584

3.  A 41-year-old woman with paroxysmal abdominal pain, weight loss and an epigastric bruit.

Authors:  Antonella Marcoccia; Marco Di Tola; Francesca Paris; Giuseppe Donato; Valerio Libanori; Antonio Picarelli
Journal:  Intern Emerg Med       Date:  2009-09-29       Impact factor: 3.397

4.  Recurrent abdominal pain and weight loss in an adolescent: celiac artery compression syndrome.

Authors:  Sarah Gander; Daniel J Mulder; Sarah Jones; John D Ricketts; Don A Soboleski; Christopher J Justinich
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

Review 5.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

6.  Celiac Axis Compression Syndrome: A Syndrome of Delayed Diagnosis?

Authors:  Dhivya Prabhakar; Deepak Venkat; Gregory S Cooper
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-03

7.  A predictive model for patients with median arcuate ligament syndrome.

Authors:  Fred Brody; James A Randall; Richard L Amdur; Anton N Sidawy
Journal:  Surg Endosc       Date:  2018-05-29       Impact factor: 4.584

8.  Robotic-assisted laparoscopic median arcuate ligament release: 7-year experience from a single tertiary care center.

Authors:  Usah Khrucharoen; Yen-Yi Juo; Yas Sanaiha; Yijun Chen; Juan C Jimenez; Erik P Dutson
Journal:  Surg Endosc       Date:  2018-05-21       Impact factor: 4.584

9.  Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

Authors:  I Soykan; B Sivri; I Sarosiek; B Kiernan; R W McCallum
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Origins and patterns of spontaneous and drug-induced canine gastric myoelectrical dysrhythmia.

Authors:  L W Qian; Pankaj Jay Pasricha; J D Z Chen
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.